Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001567619-22-014304
Filing Date
2022-07-21
Accepted
2022-07-21 16:44:59
Documents
2
Period of Report
2022-07-19

Document Format Files

Seq Description Document Type Size
1 FORM 3 doc1.html 3  
1 FORM 3 doc1.xml 3 1686
2 POWER OF ATTORNEY poa.txt EX-24.1 3723
  Complete submission text file 0001567619-22-014304.txt   6840
Mailing Address 7380 COCA COLA DRIVE SUITE 106 HANOVER MD 21076
Business Address 7380 COCA COLA DRIVE SUITE 106 HANOVER MD 21076 443-776-3133
Processa Pharmaceuticals, Inc. (Issuer) CIK: 0001533743 (see all company filings)

IRS No.: 451539785 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 2910 SEVENTH STREET BERKELEY CA 94710
Business Address
Neal James R (Reporting) CIK: 0001600865 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39531 | Film No.: 221097545